Dr. Oz: Drugmakers' narrative that lower costs will impact innovation 'is false'

Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz said Friday that the narrative that lower drug costs for Americans will hurt innovation in the field is false.